日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511]

对“在英国接种两剂 ChAdOx1 nCov-19 或 BNT162b2 后,作为第三剂加强针接种的七剂 COVID-19 疫苗的免疫原性持久性:COV-BOOST 试验的三个月分析”的更正 [J Infect 84(6) (2022) 795-813, 5511]

Liu, Xinxue; Munro, Alasdair Ps; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dejnirattisai, Wanwisa; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kwok, Jonathan; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Serafimova, Teona; Saralaya, Dinesh; Screaton, Gavin R; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Supasa, Piyada; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial

英国异源和同源新冠疫苗第三剂接种方案后免疫反应的持久性:COV-BOOST试验的八个月分析

Liu, Xinxue; Munro, Alasdair P S; Wright, Annie; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baker, Jonathan; Baxter, David; Bawa, Tanveer; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Fox, Lauren; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Haughney, John; Hicks, Alexander; Jones, Christine E; Kanji, Nasir; van der Klaauw, Agatha A; Libri, Vincenzo; Llewelyn, Martin J; Mansfield, Rebecca; Maallah, Mina; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Belhadef, Hanane Trari; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Stokes, Matthew; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

在接种两剂 ChAdOx1 nCoV-19 或 BNT162b2 疫苗后,再接种第三剂 BNT162b2 疫苗(COV-BOOST),评估 BNT162b2 和 mRNA-1273 COVID-19 疫苗作为第四剂加强针的安全性、免疫原性和反应原性:一项多中心、双盲、II 期随机试验

Munro, Alasdair P S; Feng, Shuo; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kanji, Nasir; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Maallah, Mina; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Bawa, Tanveer; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D; Liu, Xinxue; Faust, Saul N

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial

在英国,接种两剂 ChAdOx1 nCov-19 或 BNT162b2 疫苗后,再接种第三剂 COVID-19 疫苗,七例患者接种后免疫原性持久性:COV-BOOST 试验的三个月分析

Liu, Xinxue; Munro, Alasdair P S; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dejnirattisai, Wanwisa; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kwok, Jonathan; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Serafimova, Teona; Saralaya, Dinesh; Screaton, Gavin R; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Supasa, Piyada; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study)

在疫情早期阶段,英格兰因 COVID-19 住院的 HIV 感染者和非 HIV 感染者的临床结果:一项匹配的回顾性多中心分析(RECEDE-C19 研究)

Lee, Ming Jie; Snell, Luke Blagdon; Douthwaite, Sam T; Fidler, Sarah; Fitzgerald, Naomi; Goodwin, Lynsey; Hamzah, Lisa; Kulasegaram, Ranjababu; Lawrence, Sarah; Lwanga, Julianne; Marchant, Rebecca; Orkin, Chloe; Palfreeman, Adrian; Parthasarathi, Padmini; Pareek, Manish; Ring, Kyle; Sharaf, Hamed; Shekarchi-Khanghahi, Eleanor; Simons, Rebecca; Teh, Jhia Jiat; Thornhill, John; van Halsema, Clare; Williamson, Marie; Wiselka, Martin; Nori, Achyuta; Fox, Julie; Smith, Colette

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

在英国开展的一项名为“COV-BOOST”的研究,旨在评估七种新冠疫苗作为第三剂(加强剂)在接种两剂 ChAdOx1 nCov-19 或 BNT162b2 疫苗后的安全性和免疫原性:一项双盲、多中心、随机、对照的 II 期临床试验。

Munro, Alasdair P S; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Gokani, Karishma; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kwok, Jonathan; Lambe, Teresa; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Murira, Jennifer; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Salkeld, Jo; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D; Liu, Xinxue; Faust, Saul N

Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial.

炎症生物标志物在 START 试验中 HIV 阳性参与者高血压患病率和发病率中的作用

Ghazi Lama, Baker Jason V, Sharma Shweta, Jain Mamta K, Palfreeman Adrian, Necsoi Coca, Murray Daniel D, Neaton James D, Drawz Paul E

ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial.

HIV 感染者治疗前病毒载量低的抗逆转录病毒疗法:START 试验的结果

Sereti Irini, Gulick Roy M, Krishnan Sonya, Migueles Stephen A, Palfreeman Adrian, Touzeau-Römer Veronique, Belloso Waldo H, Emery Sean, Law Matthew G

Inflammation-Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It?

HIV 感染成人炎症相关发病率和死亡率:究竟有多高?

Hart, Brian B; Nordell, Anna D; Okulicz, Jason F; Palfreeman, Adrian; Horban, Andrzej; Kedem, Eynat; Neuhaus, Jacqueline; Jacobs, David R Jr; Duprez, Daniel A; Neaton, James D

Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection

立即进行抗逆转录病毒治疗可降低早期 HIV 感染期间发生感染相关癌症的风险

Borges, Álvaro H; Neuhaus, Jacqueline; Babiker, Abdel G; Henry, Keith; Jain, Mamta K; Palfreeman, Adrian; Mugyenyi, Peter; Domingo, Pere; Hoffmann, Christian; Read, Tim R H; Pujari, Sanjay; Meulbroek, Michael; Johnson, Margaret; Wilkin, Timothy; Mitsuyasu, Ronald